Turn Risk Signals Into Proportionate Site Oversight

CluePoints Site Profile & Oversight Tool (SPOT) translates central monitoring risk signals into objective, multi-factor site risk scores, so monitoring decisions are driven by data rather than intuition or fixed schedules. Study managers and Clinical Research Associates (CRAs) see exactly which sites need attention, why, and what level of oversight is proportionate. Every decision is documented and defensible, which is exactly what ICH E6(R3) proportionate oversight requires in practice.

Request a Demo

Explore RBQM

Objective Prioritization, Adaptive Monitoring,  Complete Documentation

CluePoints SPOT takes the risk intelligence generated by the Central Monitoring Platform (CMP) and converts it into prioritized, explainable site-level oversight decisions. Every capability below is designed to make monitoring proportionate, data-driven, and inspection-ready, automatically, at every site, across every study.

Data-Driven Site Risk Scoring

Calculate a composite risk score for each site using central monitoring signals, on-site workload data, and operational factors, providing study teams with an objective, continuously updated prioritization of where monitoring effort will have the greatest impact.

Targeted SDV & SDR Strategies

Replace fixed-rate Source Data Verification (SDV) schedules with risk-tiered verification and review strategies tailored to each site's current risk profile, reducing low-value 100% SDV while protecting data quality and patient safety at the sites that matter most.

Adaptive Site Visit Planning

Dynamically adjust visit frequency and on-site monitoring scope based on each site's risk score and workload, optimizing CRA deployment, reducing unnecessary visits, and ensuring monitoring intensity matches actual risk at every point in the study.

Signal-to-Action Workflow

Convert every CMP risk signal into a documented site-level action with a clear rationale: risk identified, oversight decision made, action taken, resolution confirmed. The full thread is captured automatically in a 21 CFR Part 11-compliant audit trail.

CRA Performance & Review Tracking

Give study leadership and QA real-time visibility into CRA review completion rates, visit outcomes, and oversight consistency, ensuring execution aligns with the monitoring plan and that performance gaps are promptly identified and addressed.

CTMS Integration & Flexible Deployment

Integrate SPOT with existing Clinical Trial Management System (CTMS) platforms via application programming interfaces (APIs), so risk-prioritized site lists and monitoring recommendations flow directly into operational monitoring workflows without requiring teams to change the tools they already use.

How Teams Use CluePoints SPOT

Know Which Sites Need Attention and Exactly Why

Traditional site prioritization relies on CRA instinct, historical relationships, and whatever the last monitoring visit revealed. SPOT replaces that with a continuously updated, multi-factor risk score for every site, incorporating CMP central monitoring signals, on-site workload, and operational performance data. Study managers see a ranked list of sites, along with the specific signals driving each site’s score. When Sponsors or regulators ask why a site received more or less oversight, the answer is already documented: specific, objective, and proportionate.

Right Level of Oversight for Every Site, Every Visit

SPOT directly links site risk scores to monitoring-intensity decisions, adjusting SDV scope, visit frequency, and CRA focus based on current risk rather than on a fixed protocol. High-risk sites receive targeted oversight. Lower-risk sites are monitored proportionately. This model reduces unnecessary on-site visits, which typically account for 40–60% of trial costs, without compromising the Sponsor's ability to demonstrate appropriate oversight. Every scope decision is documented with its risk basis, making the monitoring plan defensible for inspection from day one.

A Complete Oversight Narrative, from Signal to Resolution

Every monitoring decision made in SPOT is timestamped, attributed, and stored in a 21 CFR Part 11-compliant environment. When inspectors review the study, the oversight narrative is already complete: which sites were prioritized and why, what monitoring was applied, and how risk evolved over the study lifecycle. SPOT eliminates the inspection risk that comes from monitoring decisions made on instinct without a defensible, traceable record. TMF export is one click.

REGULATORY-GRADE RBQM

Proportionate Oversight, Documented and Defensible

Regulatory-grade Risk-Based Quality Management (RBQM) requires Sponsors to demonstrate that monitoring decisions are proportionate to the risks identified and documented with sufficient traceability for inspectors. CluePoints SPOT operationalizes both: adaptive monitoring decisions are made based on documented risk signals, applied consistently across all sites, and captured automatically in a complete, inspection-ready record. That is what proportionate oversight looks like in practice under ICH E6(R3).

Download the Guide

PART OF THE RBQM PLATFORM

Action Without Detection Is Guesswork. RBQM Connects Both.

CluePoints SPOT provides the site-level action layer. CluePoints Central Monitoring Platform (CMP) provides the portfolio-wide risk detection that drives it. Together, CMP and SPOT form CluePoints Risk-Based Quality Management (RBQM): from a risk signal detected centrally through monitoring to a decision made at the site level to an outcome documented in an inspection-ready audit trail. SPOT alone is action. RBQM is the operating model.

Explore CluePoints RBQM